サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1390737

オピオイド市場レポート：製品タイプ、用途、流通チャネル、地域別、2023-2028年

Opioids Market Report by Product Type, Application, Distribution Channel, and Region 2023-2028
出版日: | 発行: IMARC | ページ情報: 英文 141 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.53円
オピオイド市場レポート：製品タイプ、用途、流通チャネル、地域別、2023-2028年
出版日: 2023年11月24日
発行: IMARC
ページ情報: 英文 141 Pages
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

概要

世界のオピオイド市場規模は2022年に212億米ドルに達しました。今後、IMARC Groupは、2028年には256億米ドルに達し、2022～2028年の成長率（CAGR）は3.19%になると予測しています。慢性疼痛疾患の罹患率の上昇、高齢者人口の増加、がん診断の増加、ヘルスケアサービスへのアクセスの改善、研究開発（R&D）の継続的な取り組み、消費者の意識の高まり、有利な政府規制などは、市場を推進する主な要因の一部です。

麻薬としても知られるオピオイドは、アヘン科のケシ植物に由来する、あるいは研究所で合成された、強力な鎮痛薬の一種です。これらの物質は、脳や脊髄にある特定の受容体（主にミューオピオイド受容体）に作用し、痛みを和らげ、多幸感を誘発します。オピオイドは、重度の疼痛を管理するためにヘルスケア専門家によって合法的に処方される処方オピオイドと、医師の監督なしに入手・使用されるヘロインのような非合法オピオイドに分類されます。最も一般的な処方オピオイドは、オキシコドン、ヒドロコドン、フェンタニルなどです。

がん関連疼痛や筋骨格系障害などの慢性疼痛疾患の蔓延拡大は、重度かつ持続的な疼痛の管理のためにオピオイドの処方を必要とする主な促進要因です。これに加えて、高齢者が加齢に関連した病気や痛みを頻繁に経験することから、世界の人口動態の高齢化がオピオイド需要の増加に寄与しています。さらに、オピオイドは術後の疼痛管理によく使用されるため、世界の外科手術の急増がオピオイドの需要を押し上げ、市場拡大に寄与しています。これに加えて、特に新興諸国ではがんの診断が増加しており、がん関連の疼痛管理にオピオイドを採用する動きが加速しています。さらに、新興市場ではヘルスケアサービスへのアクセスが向上しているため、医療提供者が疼痛管理のニーズに対応するためにオピオイドの処方率が上昇しており、市場の成長を後押ししています。

オピオイド市場の動向と促進要因

慢性疼痛の増加

世界中で慢性疼痛が増加していることは、オピオイド市場の成長を促す重要な要因です。慢性疼痛は、関節炎、腰痛、神経障害などの症状から生じることが多く、数百万人が罹患しており、効果的な疼痛管理ソリューションが必要とされています。オピオイドは激痛を和らげる効能があるため、ヘルスケア専門医によって広く処方されています。これと同時に、人口が高齢化し平均寿命が延びるにつれて、慢性疼痛の発生率も増加し、オピオイドの需要を押し上げると予想されています。これに加え、疼痛関連疾患の診断と認知度の向上が、製薬企業による研究開発（R&D）への投資を促し、安全性プロファイルを強化した革新的なオピオイド製剤の創出を促し、市場の拡大をさらに促進しています。

人口の高齢化

高齢化社会への世界の人口動態の変化も、オピオイド市場の主要な促進要因の一つです。高齢者は、変性性関節疾患やがんなど、加齢に関連した疾患を経験することが多く、慢性疼痛の事例が増加するため、オピオイドなどの疼痛管理オプションに対する需要が高まっています。オピオイドは、その潜在的な副作用やリスクにもかかわらず、この層における中等度から重度の疼痛管理によく処方される選択肢であり続けています。ヘルスケア提供者は、他の疼痛管理戦略が不十分であることが判明した場合、オピオイドに頼ることが多いです。このような持続的な需要がオピオイド市場を強化しており、製薬会社は高齢化社会特有のニーズに対応するために新しい製剤や市場開拓方法を開発しています。

世界のがん罹患率の上昇

特に新興市場におけるがん罹患率の増加が、オピオイド需要の急増に寄与しています。がんは一般的な症状として激しい疼痛を示すことが多く、オピオイドはがん疼痛管理の要となっています。がんの罹患率が世界的に上昇を続ける中、効果的な疼痛緩和手段に対する需要も増加し、オピオイド市場の成長に拍車をかけています。さらに、ヘルスケアサービスへのアクセスが向上したことで、がんの診断と治療が早期に行われるようになり、疼痛管理にオピオイドを使用する必要性が高まっています。製薬企業は、がん患者特有の疼痛プロファイルに対応するよう設計された特殊なオピオイド製剤を開発することでこの需要に応えており、がん治療におけるオピオイドの役割はさらに強固なものとなり、市場拡大の原動力となっています。

本レポートで扱う主な質問

  • 世界のオピオイド市場はこれまでどのように推移し、今後数年間はどのように推移するのか？
  • 世界のオピオイド市場における促進要因、抑制要因、機会は何か？
  • それぞれの促進要因、抑制要因、機会が世界のオピオイド市場に与える影響は？
  • 主要な地域市場は？
  • 最も魅力的なオピオイド市場はどの国か？
  • 製品タイプ別の市場内訳は？
  • オピオイド市場で最も魅力的な製品タイプは？
  • 用途別の市場内訳は？
  • オピオイド市場で最も魅力的な用途は？
  • 販売チャネル別の市場内訳は？
  • オピオイド市場で最も魅力的な流通チャネルはどこか？
  • 世界のオピオイド市場の競争構造は？
  • 世界のオピオイド市場における主要プレーヤー・企業は？

目次

第1章 序文

第2章 調査範囲と調査手法

  • 調査目的
  • 利害関係者
  • データソース
    • 一次情報
    • 二次情報
  • 市場推定
    • ボトムアップアプローチ
    • トップダウンアプローチ
  • 調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

  • 概要
  • 主要産業動向

第5章 世界のオピオイド市場

  • 市場概要
  • 市場実績
  • COVID-19の影響
  • 市場予測

第6章 市場内訳：製品タイプ別

  • コデイン
    • 市場動向
    • 市場予測
  • フェンタニル
    • 市場動向
    • 市場予測
  • メタドン
    • 市場動向
    • 市場予測
  • オキシコドン
    • 市場動向
    • 市場予測
  • モルヒネ
    • 市場動向
    • 市場予測
  • ヒドロコドン
    • 市場動向
    • 市場予測

第7章 市場内訳：用途別

  • 疼痛管理
    • 市場動向
    • 市場予測
  • 咳治療薬
    • 市場動向
    • 市場予測
  • 下痢治療薬
    • 市場動向
    • 市場予測
  • その他
    • 市場動向
    • 市場予測

第8章 市場内訳：流通チャネル別

  • 病院薬局
    • 市場動向
    • 市場予測
  • 小売薬局
    • 市場動向
    • 市場予測
  • ドラッグストア
    • 市場動向
    • 市場予測
  • オンラインストア
    • 市場動向
    • 市場予測
  • その他
    • 市場動向
    • 市場予測

第9章 市場内訳：地域別

  • 北米
    • 米国
      • 市場動向
      • 市場予測
    • カナダ
      • 市場動向
      • 市場予測
  • アジア太平洋
    • 中国
      • 市場動向
      • 市場予測
    • 日本
      • 市場動向
      • 市場予測
    • インド
      • 市場動向
      • 市場予測
    • 韓国
      • 市場動向
      • 市場予測
    • オーストラリア
      • 市場動向
      • 市場予測
    • インドネシア
      • 市場動向
      • 市場予測
    • その他
      • 市場動向
      • 市場予測
  • 欧州
    • ドイツ
      • 市場動向
      • 市場予測
    • フランス
      • 市場動向
      • 市場予測
    • 英国
      • 市場動向
      • 市場予測
    • イタリア
      • 市場動向
      • 市場予測
    • スペイン
      • 市場動向
      • 市場予測
    • ロシア
      • 市場動向
      • 市場予測
    • その他
      • 市場動向
      • 市場予測
  • ラテンアメリカ
    • ブラジル
      • 市場動向
      • 市場予測
    • メキシコ
      • 市場動向
      • 市場予測
    • その他
      • 市場動向
      • 市場予測
  • 中東・アフリカ地域
    • 市場動向
    • 市場内訳：国別
    • 市場予測

第10章 SWOT分析

  • 概要
  • 強み
  • 弱み
  • 機会
  • 脅威

第11章 バリューチェーン分析

第12章 ポーターのファイブフォース分析

  • 概要
  • 買い手の交渉力
  • 供給企業の交渉力
  • 競合の程度
  • 新規参入業者の脅威
  • 代替品の脅威

第13章 価格分析

第14章 競合情勢

  • 市場構造
  • 主要企業
  • 主要企業のプロファイル
    • Boehringer Ingelheim International GmbH
    • Hikma Pharmaceuticals PLC
    • Mallinckrodt plc
    • Pfizer Inc.
    • Purdue Pharma L.P.
    • Sanofi S.A.
    • Sun Pharmaceutical Industries Ltd.
    • Teva Pharmaceutical Industries Ltd.
図表

List of Figures

  • Figure 1: Global: Opioids Market: Major Drivers and Challenges
  • Figure 2: Global: Opioids Market: Sales Value (in Billion US$), 2017-2022
  • Figure 3: Global: Opioids Market Forecast: Sales Value (in Billion US$), 2023-2028
  • Figure 4: Global: Opioids Market: Breakup by Product Type (in %), 2022
  • Figure 5: Global: Opioids Market: Breakup by Application (in %), 2022
  • Figure 6: Global: Opioids Market: Breakup by Distribution Channel (in %), 2022
  • Figure 7: Global: Opioids Market: Breakup by Region (in %), 2022
  • Figure 8: Global: Opioids (Codeine) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 9: Global: Opioids (Codeine) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 10: Global: Opioids (Fentanyl) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 11: Global: Opioids (Fentanyl) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 12: Global: Opioids (Methadone) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 13: Global: Opioids (Methadone) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 14: Global: Opioids (Oxycodone) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 15: Global: Opioids (Oxycodone) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 16: Global: Opioids (Morphine) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 17: Global: Opioids (Morphine) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 18: Global: Opioids (Hydrocodone) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 19: Global: Opioids (Hydrocodone) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 20: Global: Opioids (Pain Management) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 21: Global: Opioids (Pain Management) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 22: Global: Opioids (Cough Treatment) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 23: Global: Opioids (Cough Treatment) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 24: Global: Opioids (Diarrhea Treatment) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 25: Global: Opioids (Diarrhea Treatment) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 26: Global: Opioids (Other Applications) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 27: Global: Opioids (Other Applications) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 28: Global: Opioids (Hospital Pharmacies) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 29: Global: Opioids (Hospital Pharmacies) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 30: Global: Opioids (Retail Pharmacies) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 31: Global: Opioids (Retail Pharmacies) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 32: Global: Opioids (Drug Stores) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 33: Global: Opioids (Drug Stores) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 34: Global: Opioids (Online Stores) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 35: Global: Opioids (Online Stores) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 36: Global: Opioids (Other Distribution Channels) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 37: Global: Opioids (Other Distribution Channels) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 38: North America: Opioids Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 39: North America: Opioids Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 40: United States: Opioids Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 41: United States: Opioids Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 42: Canada: Opioids Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 43: Canada: Opioids Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 44: Asia-Pacific: Opioids Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 45: Asia-Pacific: Opioids Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 46: China: Opioids Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 47: China: Opioids Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 48: Japan: Opioids Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 49: Japan: Opioids Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 50: India: Opioids Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 51: India: Opioids Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 52: South Korea: Opioids Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 53: South Korea: Opioids Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 54: Australia: Opioids Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 55: Australia: Opioids Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 56: Indonesia: Opioids Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 57: Indonesia: Opioids Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 58: Others: Opioids Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 59: Others: Opioids Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 60: Europe: Opioids Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 61: Europe: Opioids Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 62: Germany: Opioids Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 63: Germany: Opioids Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 64: France: Opioids Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 65: France: Opioids Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 66: United Kingdom: Opioids Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 67: United Kingdom: Opioids Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 68: Italy: Opioids Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 69: Italy: Opioids Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 70: Spain: Opioids Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 71: Spain: Opioids Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 72: Russia: Opioids Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 73: Russia: Opioids Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 74: Others: Opioids Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 75: Others: Opioids Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 76: Latin America: Opioids Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 77: Latin America: Opioids Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 78: Brazil: Opioids Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 79: Brazil: Opioids Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 80: Mexico: Opioids Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 81: Mexico: Opioids Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 82: Others: Opioids Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 83: Others: Opioids Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 84: Middle East and Africa: Opioids Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 85: Middle East and Africa: Opioids Market: Breakup by Country (in %), 2022
  • Figure 86: Middle East and Africa: Opioids Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 87: Global: Opioids Industry: SWOT Analysis
  • Figure 88: Global: Opioids Industry: Value Chain Analysis
  • Figure 89: Global: Opioids Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Opioids Market: Key Industry Highlights, 2022 and 2028
  • Table 2: Global: Opioids Market Forecast: Breakup by Product Type (in Million US$), 2023-2028
  • Table 3: Global: Opioids Market Forecast: Breakup by Application (in Million US$), 2023-2028
  • Table 4: Global: Opioids Market Forecast: Breakup by Distribution Channel (in Million US$), 2023-2028
  • Table 5: Global: Opioids Market Forecast: Breakup by Region (in Million US$), 2023-2028
  • Table 6: Global: Opioids Market: Competitive Structure
  • Table 7: Global: Opioids Market: Key Players
目次
Product Code: SR112023A4559

Abstract

The global opioids market size reached US$ 21.2 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 25.6 Billion by 2028, exhibiting a growth rate (CAGR) of 3.19% during 2022-2028. The rising incidence of chronic pain conditions, expanding elderly population, increase in cancer diagnoses, improved access to healthcare services, ongoing research and development (R&D) efforts, escalating consumer awareness, and favorable government regulations are some of the major factors propelling the market.

Opioids, also known as narcotics, are a class of powerful pain-relieving medications derived from the opium poppy plant or synthesized in laboratories. These substances act on specific receptors in the brain and spinal cord, primarily the mu-opioid receptors, to alleviate pain and induce a sense of euphoria. Opioids can be classified into two main categories including, prescription opioids, which are legally prescribed by healthcare professionals to manage severe pain, and illicit opioids like heroin, which are obtained and used without medical supervision. The most common prescription opioids include oxycodone, hydrocodone, and fentanyl.

The expanding prevalence of chronic pain conditions, including cancer-related pain and musculoskeletal disorders, is a key driving factor necessitating the prescription of opioids for the management of severe and persistent pain. In addition to this, the global demographic shift towards an aging population is contributing to the increasing demand for opioids, as elderly individuals frequently experience age-related ailments and pain. Moreover, opioids are commonly used in post-operative pain management, consequently the significant surge in surgical procedures worldwide is boosting the demand for these medications, thereby aiding in market expansion. Besides this, the increase in cancer diagnoses, especially in developing countries, is fueling the adoption of opioids to manage cancer-related pain. Furthermore, improved access to healthcare services in emerging markets is leading to higher prescription rates for opioids as healthcare providers aim to address pain management needs, thus impelling the market growth.

Opioids Market Trends/Drivers:

Increasing prevalence of chronic pain

The escalating prevalence of chronic pain across the globe represents a significant growth-inducing driver of the opioids market. Chronic pain, often resulting from conditions such as arthritis, back problems, or neuropathic disorders, affects millions of individuals, necessitating effective pain management solutions. Opioids are widely prescribed by healthcare practitioners due to their potency in alleviating severe pain. Concurrent with this, as the population ages and life expectancy rises, the incidence of chronic pain is also expected to grow, propelling the demand for opioids. Besides this, improved diagnosis and awareness of pain-related disorders are prompting pharmaceutical companies to invest in research and development (R&D) to create innovative opioid formulations with enhanced safety profiles, further driving the market's expansion.

Aging population

The global demographic shift toward an aging population is another key driver of the opioids market. Elderly individuals often experience age-related ailments, including degenerative joint diseases and cancer, leading to increased instances of chronic pain, which, in turn, is fueling the demand for pain management options, such as opioids. Opioids, despite their potential side effects and risks, remain a commonly prescribed option for managing moderate to severe pain in this demographic. Healthcare providers often resort to opioids when other pain management strategies prove inadequate. This sustained demand has strengthened the opioid market, as pharmaceutical companies develop new formulations and delivery methods to cater to the specific needs of the aging population.

Rising cancer rates across the globe

The increasing incidence of cancer diagnoses, particularly in emerging markets, is contributing to the surging demand for opioids. Cancer often presents severe pain as a common symptom, and opioids are a cornerstone of cancer pain management. As cancer rates continue to rise globally, so does the demand for effective pain relief measures, fueling the opioid market's growth. Moreover, improved access to healthcare services is leading to earlier cancer diagnosis and treatment, necessitating the use of opioids for pain management. Pharmaceutical companies are responding to this demand by developing specialized opioid formulations designed to cater to the unique pain profiles of cancer patients, further solidifying the role of opioids in cancer care and driving market expansion.

Opioids Industry Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the global opioids market report, along with forecasts at the global, regional and country levels from 2023-2028. Our report has categorized the market based on product type, application and distribution channel.

Breakup by Product Type:

Codeine

Fentanyl

Methadone

Oxycodone

Morphine

Hydrocodone

Oxycodone holds the largest share in the market

The report has provided a detailed breakup and analysis of the market based on the product type. This includes codeine, fentanyl, methadone, oxycodone, morphine, and hydrocodone. According to the report, oxycodone represented the largest segment.

Oxycodone has emerged as a dominant product type in the opioids market for owing to its potent pain-relieving properties which make it highly effective in managing severe pain, including post-operative and cancer-related pain. Physicians often prescribe oxycodone when other pain management options prove insufficient. Moreover, the pharmaceutical industry has invested significantly in the development of extended-release formulations of oxycodone, offering prolonged pain relief with fewer dosing intervals. This convenience factor has contributed to its widespread use. Additionally, oxycodone's versatility allows for various administration routes, including oral tablets, capsules, and intravenous formulations, catering to diverse patient needs, which, in turn, is impelling its adoption. Moreover, the familiarity of healthcare providers with oxycodone's efficacy and safety profile has led to its continued use as a primary option for pain management, creating a positive outlook for market growth.

Breakup by Application:

Pain Management

Cough Treatment

Diarrhea Treatment

Others

Pain management holds the largest share in the market

A detailed breakup and analysis of the market based on the application has also been provided in the report. This includes pain management, cough treatment, diarrhea treatment, and others. According to the report, pain management accounted for the largest market share.

Opioid's fundamental role in healthcare sector and the increasing recognition of the importance of effectively addressing pain is fueling its adoption in pain management applications. Pain is a pervasive and complex medical issue affecting millions of individuals worldwide, and opioids are considered a crucial component in managing moderate to severe pain, especially in acute and chronic pain conditions, post-surgical recovery, and cancer-related pain. The sheer prevalence of pain-related conditions owing to the growing geriatric population, and the rising incidence of cancer diagnoses have created a sustained demand for effective pain relief methods, such as opioids, thereby bolstering the market growth. In addition to this, the medical community's commitment to improving the quality of life for patients has led to a growing emphasis on personalized pain management plans, where opioids are often a key element, thus, underscoring its dominance in the application segment.

Breakup by Distribution Channel:

Hospital Pharmacies

Retail Pharmacies

Drug Stores

Online Stores

Others

The report has provided a detailed breakup and analysis of the market based on the distribution channel. This includes hospital pharmacies, retail pharmacies, drug stores, online stores, and others.

The rise in prevalence of chronic pain conditions, such as osteoarthritis and lower back pain, has led to a surge in the prescription and purchase of opioid medications through retail pharmacies and drug stores, strengthening the market growth.

Additionally, the growing awareness and advocacy for pain management prompting healthcare providers to prescribe opioids for acute pain, often obtained through hospital pharmacies is influencing the market's growth.

Furthermore, the convenience of online shopping and the proliferation of online pharmacies has made opioids more accessible, contributing to increased product demand. The global opioids market is driven by the need for stringent regulations, enhanced educational efforts, and responsible prescribing practices across all distribution channels to strike a balance between meeting patients' pain relief needs and safeguarding public health.

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

North America exhibits a clear dominance, accounting for the largest opioids market share

The market research report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America accounted for the largest market share.

The North American opioids market has experienced substantial growth due to several factors, including a high prevalence of chronic pain conditions, such as back pain and osteoarthritis, an aging population, and the widespread use of opioids in pain management. In addition to this, improved healthcare infrastructure and increased awareness of pain management options have led to higher opioid prescription rates, positively impacting the market growth. Moreover, the opioid epidemic, characterized by high rates of addiction and overdose deaths, has spurred growth through the increased use of medications such as buprenorphine and methadone for addiction treatment and harm reduction. Specialized addiction treatment centers and pharmacies have emerged as distribution channels, addressing the demand for these medications. Furthermore, evolving regulations and prescribing practices, influenced by stricter guidelines and prescription monitoring programs are influencing the market growth.

Competitive Landscape:

Leading pharmaceutical companies are investing heavily in R&D to develop innovative opioid formulations. These efforts focus on creating opioids with improved safety profiles, reduced potential for abuse, and enhanced efficacy in pain management. The goal is to provide healthcare professionals with more effective and safer treatment options. Moreover, opioid manufacturers are closely monitoring and complying with evolving regulations and guidelines related to opioid prescribing, distribution, and usage. They are working to ensure that their products meet the highest safety and quality standards while adhering to stringent regulatory requirements. All these efforts are shaping the future of the opioids market.

The report has provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the key players in the market include:

Boehringer Ingelheim International GmbH

Hikma Pharmaceuticals PLC

Mallinckrodt plc

Pfizer Inc.

Purdue Pharma L.P.

Sanofi S.A.

Sun Pharmaceutical Industries Ltd.

Teva Pharmaceutical Industries Ltd.

Recent Developments:

In June 2021, the U.S. FDA accepted and granted priority review designation to new drug application (NDA) submitted by Purdue Pharma L.P. for nalmefene hydrochloride injection. Nalmefene injectable is an opioid antagonist designed to reverse opioid overdose.

In November 2022, Teva announced a novel partnership with Rimidi to broaden the respiratory digital health platform's impact.

Key Questions Answered in This Report:

  • How has the global opioids market performed so far, and how will it perform in the coming years?
  • What are the drivers, restraints, and opportunities in the global opioids market?
  • What is the impact of each driver, restraint, and opportunity on the global opioids market?
  • What are the key regional markets?
  • Which countries represent the most attractive opioids market?
  • What is the breakup of the market based on the product type?
  • Which is the most attractive product type in the opioids market?
  • What is the breakup of the market based on application?
  • Which is the most attractive application in the opioids market?
  • What is the breakup of the market based on distribution channel?
  • Which is the most attractive distribution channel in the opioids market?
  • What is the competitive structure of the global opioids market?
  • Who are the key players/companies in the global opioids market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Opioids Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product Type

  • 6.1 Codeine
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Fentanyl
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Methadone
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Oxycodone
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast
  • 6.5 Morphine
    • 6.5.1 Market Trends
    • 6.5.2 Market Forecast
  • 6.6 Hydrocodone
    • 6.6.1 Market Trends
    • 6.6.2 Market Forecast

7 Market Breakup by Application

  • 7.1 Pain Management
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Cough Treatment
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Diarrhea Treatment
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Others
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast

8 Market Breakup by Distribution Channel

  • 8.1 Hospital Pharmacies
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Retail Pharmacies
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Drug Stores
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Online Stores
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast
  • 8.5 Others
    • 8.5.1 Market Trends
    • 8.5.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Boehringer Ingelheim International GmbH
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
    • 14.3.2 Hikma Pharmaceuticals PLC
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
      • 14.3.2.3 Financials
      • 14.3.2.4 SWOT Analysis
    • 14.3.3 Mallinckrodt plc
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
    • 14.3.4 Pfizer Inc.
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
      • 14.3.4.4 SWOT Analysis
    • 14.3.5 Purdue Pharma L.P.
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
    • 14.3.6 Sanofi S.A.
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 Financials
      • 14.3.6.4 SWOT Analysis
    • 14.3.7 Sun Pharmaceutical Industries Ltd.
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 Financials
      • 14.3.7.4 SWOT Analysis
    • 14.3.8 Teva Pharmaceutical Industries Ltd.
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 Financials
      • 14.3.8.4 SWOT Analysis